LCPUFA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) to cardioprotection ( 1, 2 ). As a consequence, increased consumption of food-based sources of EPA and DHA has been recommended in most nutritional guidelines issued by government and health organizations, such as American Heart Association ( 3 ). Although oily fi sh is the richest dietary source of EPA and DHA, its consumption in most Western countries is low and inadequate to provide the recommended daily intake (250-500 mg of EPA and DHA) ( 3 ). Vegetable oils, such as fl axseed, soybean, and canola oil, and nuts, such as English walnuts, that are enriched in ␣ -linolenic acid (ALA) can serve as alternative sources of EPA and DHA. ALA is referred to as the essential precursor of n-3 LCPUFA because its further elongation and desaturation leads to the formation of EPA and DHA ( 4 ). However, the rate of conversion of ALA to EPA is low ( ف 5%) and to DHA even lower (<1%) and can be modifi ed by several factors, such as dietary cholesterol, n-6 PUFA intake, and gender-related hormones ( 5 ).The atheroprotective potential of ALA has been questioned for a long time but not yet extensively investigated. To date, studies in humans have reported that (a) ALA supplementation results in its rapid incorporation into lipoproteins and elevated plasma ALA, EPA, and docosapentaenoic acid (DPA) but not DHA concentrations ( 6, 7 ); (b) ALA intake is inversely associated with nonfatal acute